Nikolaos Tertipis
Overview
Explore the profile of Nikolaos Tertipis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
392
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sohrabi A, Franzen J, Tertipis N, Zagai U, Li W, Zheng Z, et al.
Diagnostics (Basel)
. 2021 Sep;
11(9).
PMID: 34573879
For targeted eradication of () to reduce gastric cancer burden, a convenient approach is definitely needed. The purpose of this study was to evaluate the LAMP assay for detection using...
2.
Bersani C, Mints M, Tertipis N, Haeggblom L, Nasman A, Romanitan M, et al.
Oral Oncol
. 2018 Jun;
82:8-16.
PMID: 29909906
Objective: Three-year disease-free survival (DFS) is 80% for human papillomavirus (HPV) positive tonsillar and base of tongue cancer (TSCC/BOTSCC) treated with radiotherapy alone, and today's intensified therapy does not improve...
3.
Bersani C, Sivars L, Haeggblom L, DiLorenzo S, Mints M, Ahrlund-Richter A, et al.
Oncotarget
. 2017 May;
8(21):35339-35350.
PMID: 28525363
Background: Human papillomavirus positive (HPV+) tonsillar cancer (TSCC), base of tongue cancer (BOTSCC) and unknown primary cancer of the head and neck (HNCUP) have better outcome than corresponding HPV- cancers....
4.
Bersani C, Mints M, Tertipis N, Haeggblom L, Sivars L, Ahrlund-Richter A, et al.
Oral Oncol
. 2017 Apr;
68:53-59.
PMID: 28438294
Objective: Head-neck cancer therapy has become intensified. With radiotherapy alone, 3-year disease-free survival (DFS) is 80% for HPV-positive TSCC/BOTSCC and better for patients with favorable characteristics, suggesting therapy could be...
5.
Haeggblom L, Nordfors C, Tertipis N, Bersani C, Ramqvist T, Nasman A, et al.
Int J Oncol
. 2017 Mar;
50(4):1423-1430.
PMID: 28350079
Human papillomavirus (HPV) infection is a risk factor for oropharyngeal cancer, besides smoking and alcohol. Patients with HPV-positive tumors have a better prognosis than those with HPV-negative tumors. Furthermore, patients...
6.
Sivars L, Landin D, Haeggblom L, Tertipis N, Grun N, Bersani C, et al.
Head Neck
. 2016 Nov;
39(3):419-426.
PMID: 27898186
Background: Human papillomavirus (HPV)-positive oropharyngeal squamous cell carcinoma (SCC) has a better outcome than most head neck squamous cell carcinomas (HNSCCs) and an HPV-positive lymph node metastasis likely has an...
7.
Ramqvist T, Mints M, Tertipis N, Nasman A, Romanitan M, Dalianis T
Oral Oncol
. 2015 Oct;
51(12):1126-31.
PMID: 26421862
Objectives: Three-year survival is 80% for human papillomavirus (HPV) positive tonsillar and base of tongue squamous cell carcinoma (TSCC and BOTSCC) and higher (95-100%) in patients with tumors without HLA...
8.
Dalianis T, Grun N, Koch J, Vlastos A, Tertipis N, Nordfors C, et al.
Oral Oncol
. 2015 Jun;
51(9):857-61.
PMID: 26120094
Objectives: Hypopharyngeal cancer is a subset of head neck squamous cell carcinoma (HNSCC) with particularly poor prognosis. Human papillomavirus (HPV) is a risk factor for some HNSCC, and its presence...
9.
Wadelin F, Fulton J, Collins H, Tertipis N, Bottley A, Spriggs K, et al.
PLoS One
. 2015 Jun;
10(6):e0129297.
PMID: 26068868
No abstract available.
10.
Tertipis N, Hammar U, Nasman A, Vlastos A, Nordfors C, Grun N, et al.
Eur J Cancer
. 2015 May;
51(12):1580-7.
PMID: 26025766
Aim: To combine clinical and molecular markers into an algorithm for predicting outcome for individual patients with human papillomavirus (HPV) DNA/p16(INK4a) positive tonsillar and base of tongue squamous cell carcinoma...